In 1999, the 5-year survival rate for pancreatic cancer was just 4%. In 2023, the survival rate has tripled to 12%. Although pancreatic cancer research has advanced significantly in recent years, much more needs to be done.
Current State Of Pancreatic Cancer Research
The following are some active research areas:
- Genetics: Understanding the genetic abnormalities that contribute to the occurrence of pancreatic cancer will help researchers better understand its genetics.
- Creating Novel Medicines: Chemotherapy medications, immunotherapy, and targeted therapies are among the new pancreatic cancer treatments being created by researchers. Clinical trials for a few promising novel therapies are currently ongoing.
- Improving Early Detection: Researchers are exploring new methods for detecting pancreatic cancer in its early stages, including blood tests, imaging tests, and genetic testing.
The Importance Of Early Detection In Pancreatic Cancer
What makes pancreatic cancer cells unique? Not only do pancreatic cancer cells grow unusually fast, but they can also break off from the tumor early in the disease and spread. We know that scar tissue tends to form around the tumor, which may serve as a barrier to therapeutic agents.
There’s a complex interplay between the tumor and its environment which further protects the tumor from chemotherapy and radiation and helps it evade the immune system.
Pancreatic cancer does not discriminate. It is sometimes called a “silent cancer” since it takes time to present any symptoms and is often untreatable once detected.
The Impact Of Donations On Early Detection Pancreatic Cancer Research
Despite the progress being made, funding for pancreatic cancer research is still relatively low compared to other cancers. Pancreatic Cancer is the deadliest common cancer, yet it receives less than 3% of cancer research funding.
There have been several successful research projects funded by donations that have contributed to our understanding of pancreatic cancer and improved patient outcomes.
Earlier detection can save lives. Pancreatic cancer is most treatable in its early stages. Earlier detection means more patients could be eligible for surgery to remove their tumors, which could lead to significantly higher survival rates.
The gift of health can change the world. Your donations WILL help save lives. Donate Today!
Without early diagnosis and intervention, most patients are diagnosed when their cancer has progressed to a late stage, leaving patients and their loved ones feeling hopeless.
At TrovaNOW, our mission is to increase pancreatic cancer survival rates through research, early detection, and prevention strategies.
Research and innovation are critical for creating breakthroughs that will improve the lives of pancreatic cancer patients.
What could the future of early detection for pancreatic cancer look like? We are working to find a way to detect this deadly cancer at its earliest stages, either through a blood test or other means, so that the cancer can be removed and stopped in its tracks.
We encourage you to join us in supporting pancreatic cancer patients and their families through early detection and prevention. We are not powerless against pancreatic cancer. We are fighting the fight while finding the cure – but we can’t do it alone.
If you have any questions or If you want more information just email us at trovanow@gmail.com or visit http://trovanow.com to learn how you can get involved and donate today.
